|
|
|
Insider
Information: |
Gold Mitchell |
Relationship: |
Executive Chairman and... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
457,263 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
457,263 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNDN |
Dendreon Corp |
CEO |
|
2003-09-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
35,000 |
39,990 |
|
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2006-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
112,500 |
219,683 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2007-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
244,138 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2007-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
112,500 |
301,986 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
93,180 |
393,885 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2009-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
175,000 |
552,546 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2010-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,250 |
515,984 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2010-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
245,435 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & Chief Executive Of |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
56,101 |
294,926 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & Chief Executive Of |
|
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
460,000 |
682,277 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
457,263 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,878,441 |
3,803,906 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
23,292 |
23,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2018-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
20,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2018-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
17,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2018-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
11,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2019-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
6,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2019-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,292 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
67,569 |
68,861 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2020-12-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(993,801) |
3,000,980 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2020-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
260,528 |
321,162 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
96,000 |
96,000 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2024-05-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,627,157) |
0 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2024-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(109,245) |
0 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-12 |
4 |
OE |
$0.45 |
$3,876 |
D/D |
8,613 |
8,613 |
0 |
- |
|
140 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|